O-34 - Pediatric Vaccines

Co-Author(s)

• WB

  William Barson, MD

  Professor
  Ohio State University College of Medicine and Public Health and Nationwide Children's Hospital
  Columbus, Ohio

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JB

  Julie A. Boom, MD

  Associate professor
  Pediatrics
  Baylor College of Medicine and Texas Children's Hospital
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JB

  John Bradley, MD

  Professor
  Pediatrics
  University of California San Diego/Rady Children's Hospital
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MD

  Matthew Daley, MD

  Senior Investigator
  Institute for Health Research
  Kaiser Permanente Colorado
  Aurora, Colorado

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JD

  James Donahue, DVM,PhD, MPH

  Investigator
  Marshfield Clinic Research Institute, Marshfield, Wisconsin
  Marshfield, Wisconsin

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Janet Englund, MD

  Professor
  Pediatrics
  Seattle Children's Hospital/Univ. of Washington
  Seattle, Washington

  Disclosure: AstraZeneca (Scientific Research Study Investigator)GSK group of companies (Scientific Research Study Investigator)Meissa vaccines (Consultant)Merck (Scientific Research Study Investigator)Sanofi Pasteur (Consultant)
• BF

  Bruce Fireman, MA

  Research Scientist
  Kaiser Permanente Vaccine Study Center, Oakland, California
  Oakland, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DG

  Diana Garbinsky, MS

  Statistician
  RTI Health Solutions
  Research Triangle Park, North Carolina

  Disclosure: GSK (Other Financial or Material Support, The study was conducted by RTI Health Solutions, which received consultancy fees from GSK. I am a salaried employee at RTI Health Solutions and received no direct compensation from GSK for the conduct of this study..)
• DG

  Darios Gethaun, MD, PhD, MPH

  Research Scientist
  5Kaiser Permanente Department of Research and Evaluation, Pasadena, California
  Pasadena, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Parinaz Ghaswalla, PhD, ORCID: 0000-0002-2883-5590

  Manager
  US Health Outcomes and Epidemiology - Vaccines
  GSK
  Philadelphia, Pennsylvania

  Disclosure: GlaxoSmithKline (Employee, Shareholder)
• LG

  Larry Givner, MD

  Professor of Pediatrics
  Pediatrics
  Wake Forest School of Medicine
  Winston Salem, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KG

  Kristin Goddard, MPH

  Sr. Research Project Manager
  Kaiser Permanente
  Oakland, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Natasha Halasa, MD, MPH

  Associate Professor
  Pediatrics
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: Genentech : I receive an honorarium for lectures - it's a education grant, supported by genetech, Other Financial or Material Support; Karius : Consultant; Moderna : Consultant; Quidel : Grant/Research Support, Research Grant or Support; Sanofi : Grant/Research Support, Research Grant or Support
• CH

  Christopher Harrison, MD

  Professor
  Pediatric Infectious Diseases
  The Children's Mercy Hospital- Kansas City
  Kansas City, Missouri

  Disclosure: GSK (Grant/Research Support, Infant menigiciccal B conjugate vaccine trial)Merck (Research Grant or Support, Infant pneumococcal conjugate vaccine trial)
• RH

  Robert Hickey, MD

  Professor
  Pediatrics
  Childrens Hospital of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Kristina Hulten, PhD

  Associate Professor
  Department of Pediatrics, Section of Infectious Diseases
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SH

  Shannon Hunter, MS

  Director, Biostatistics
  RTI Health Solutions
  Research Triangle Park, North Carolina

  Disclosure: GSK (Other Financial or Material Support, Ms. Hunter is an employee of RTI Health Solutions, who received consultancy fees from GSK for conduct of the study. Ms. Hunter received no direct compensation from the Sponsor.)
• SI

  Stephanie Irving, MHS

  Senior Research Associate
  Kaiser Permanente Center for Health Research
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LJ

  Lisa Jackson, MD, MPH

  Senior Investigator
  Kaiser Permanente Washington Health Research Institute
  Seattle, Washington

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• EK

  Eileen Klein, MD, MPH

  Professor
  Pediatrics
  Seattle Children's Hospital
  Seattle, Washington

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Nicola P. Klein, MD, PhD

  Director
  Kaiser Permanente Vaccine Study Center, Oakland, California, United States
  Oakland, California

  Disclosure: GSK group of companies (Research Grant or Support)Merck (Grant/Research Support)Pfizer (Grant/Research Support)Protein Science (now SP) (Grant/Research Support)Sanofi Pasteur (Grant/Research Support)
• 

  Elizabeth La, PhD

  Associate Director, Health Economics
  RTI Health Solutions
  Research Triangle Park, North Carolina

  Disclosure: RTI Health Solutions (Employee)
• NL

  Ned Lewis, MPH

  Data Manager/Group Leader
  Vaccine Study Center
  Kaiser Permanente Northern California
  Oakland, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PL

  Philana Lin, MD, MSc

  Associate Professor
  Pediatrics
  UPMC Children's Hospital of PIttsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JL

  Joana Lively, MPH

  Epidemiologist
  Division of Viral Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MM

  Monica McNeal, MS

  Co-investigator
  Infectious Diseases
  Cincinnati Children's Hospital Medical Center
  Cincinnati, Ohio

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MM

  Marian G. Michaels, MD, MPH

  Professor
  UPMC Children's Hospital of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SM

  Sharareh Modaressi, MD, MPH

  Data Analyst
  Kaiser Permanente Vaccine Study Center
  Oakland, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MM

  Mary Moffatt, MD

  Professor
  The Children's Mercy Hospital
  Kansas City, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PN

  Patricia Novy, PhD

  US Medical Affairs Lead, Meningococcal Vaccines
  GSK
  Philadelphia, Pennsylvania

  Disclosure: GSK (Employee, Shareholder)
• CO

  Constance Ogokeh, MPH

  Data Analyst
  Influenza Division
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• BP

  Barbara Pahud, MD, MPH

  Associate Professor
  The Children's Mercy Hospital
  Kansas City, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Pia Pannaraj, MD, MPH

  Associate Professor
  Pediatric Infectious Diseases
  Children's Hospital Los Angeles
  Los Angeles, California

  Disclosure: AstraZeneca (Grant/Research Support)Pfizer (Grant/Research Support)Sanofi Pasteur (Advisor or Review Panel member)
• MP

  Manish Patel, MD

  Medical Officer
  Influenza Division
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LQ

  Lei Qian, PhD

  Research Scientist I
  Research and Evaluation
  Kaiser Permanente Southern California
  Pasadena, California

  Disclosure: GlaxoSmithKlein (Research Grant or Support)
• BR

  Brian Rha, MD, MSPH

  Medical Epidemiologist
  Division of Viral Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JR

  Jose Romero, MD

  Professor
  Department of Pediatrics, Section of Infectious Diseases
  University of Arkansas for Medical Sciences and Arkansas Children's Hospital
  Little Rock, Arkansas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LS

  Leila Sahni, PhD, MPH

  Research Manager
  Texas Children’s Hospital
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Jennifer Schuster, MD

  Assistant Professor
  Children's Mercy Hospital
  Kansas City, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RS

  Rangaraj Selvarangan, BVSc, PhD

  Director, Clinical Microbiology Laboratory
  Pathology and Laboratory Medicine
  Children's Mercy Hospital
  Kansas City, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MS

  Mary Staat, MD, MPH

  Professor
  Pediatric Infectious Diseases
  Cincinnati Children's Hospital Medical Center
  Cincinnati, Ohio

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LS

  Laura S. Stewart, PhD

  Program Manager
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PS

  Peter Szilagyi, MD, MPH

  Professor
  Pediatrics
  University of California, Los Angeles
  Los Angeles, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• TT

  Tina Tan, MD

  Professor
  Department of Pediatrics
  Feinberg School of Medicine, Northwestern University
  Chicago, Illinois

  Disclosure: Pfizer (Grant/Research Support, Other Financial or Material Support, Chair, DMSB for PCV20 vaccine)
• GW

  Gina Weddle, DNP, RN, CPNP-AC/PC

  Director Advanced Practice Programs
  Patient Care Services
  Children's Mercy Hospital
  Kansas City, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• GW

  Geoffrey Weinberg, MD

  Professor
  Pediatrics
  University of Rochester
  Rochester, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JW

  John V. Williams, MD

  Professor
  Pediatric Infectious Diseases
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: GlaxoSmithKline (Advisor or Review Panel member)IDConnect (Advisor or Review Panel member)Quidel (Advisor or Review Panel member)

Presenting Author(s)

• 

  Angela Campbell, MD, MPH

  Medical Officer
  Influenza Division
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Sheldon Kaplan, MD

  Professor
  Department of Pediatrics, Section of Infectious Diseases
  Baylor College of Medicine
  Houston, Texas

  Disclosure: Allergan (Research Grant or Support)Pfizer (Grant/Research Support)

  Slides Slides and Audio
• 

  Sara Poston, PharmD

  Head, US Health Outcomes Research, Vaccines
  GSK
  Lancaster, Pennsylvania

  Disclosure: The GlaxoSmithKline group of companies (Employee, Shareholder)

  Slides Slides and Audio
• 

  Ousseny Zerbo, PhD

  Research Scientist
  Kaiser Permanente Vaccine Study Center
  Oakland, CA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• Selected Impact of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) at Eight Children's Hospitals in the United States. 2014-2019
  Sheldon L. Kaplan, MD – Baylor College of Medicine; William J. Barson, MD – Ohio State University College of Medicine and Public Health and Nationwide Children's Hospital; Philana L. Lin, MD, MSc – UPMC Children's Hospital of PIttsburgh; Jose R. Romero, MD – University of Arkansas for Medical Sciences and Arkansas Children's Hospital; John S. Bradley, MD – University of California San Diego/Rady Children's Hospital; Tina Q. Tan, MD – Feinberg School of Medicine, Northwestern University; Pia S. Pannaraj, MD, MPH – Children's Hospital Los Angeles; Larry Givner, MD – Wake Forest School of Medicine; Kristina G. Hulten, PhD – Baylor College of Medicine
• Safety of Measles and Pertussis-containing Vaccines in School-age Children Previously Diagnosed with Autism Spectrum Disorders
  Ousseny Zerbo, PhD – Kaiser Permanente Vaccine Study Center; Sharareh Modaressi, MD, MPH – Kaiser Permanente Vaccine Study Center; Kristin Goddard, MPH – Kaiser Permanente; Ned Lewis, MPH – Kaiser Permanente Northern California; Bruce Fireman, MA – Kaiser Permanente Vaccine Study Center, Oakland, California; Lisa Jackson, MD, MPH – Kaiser Permanente Washington Health Research Institute; Stephanie Irving, MHS – Kaiser Permanente Center for Health Research; Matthew F. Daley, MD – Kaiser Permanente Colorado; Darios Gethaun, MD, PhD, MPH – 5Kaiser Permanente Department of Research and Evaluation, Pasadena, California; Lei Qian, PhD – Kaiser Permanente Southern California; James Donahue, DVM,PhD, MPH – Marshfield Clinic Research Institute, Marshfield, Wisconsin; Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center, Oakland, California, United States
• Vaccine Effectiveness Against Influenza-associated Hospitalizations and Emergency Department (ED) Visits Among Children in the United States in the 2019–2020 Season
  Angela P. Campbell, MD, MPH – Centers for Disease Control and Prevention; Constance E. Ogokeh, MPH – Centers for Disease Control and Prevention; Geoffrey A. Weinberg, MD – University of Rochester; Julie A. Boom, MD – Baylor College of Medicine and Texas Children's Hospital; Janet A. Englund, MD – Seattle Children's Hospital/Univ. of Washington; John V. Williams, MD – University of Pittsburgh; Natasha B. Halasa, MD, MPH – Vanderbilt University Medical Center; Rangaraj Selvarangan, BVSc, PhD – Children's Mercy Hospital; Mary A. Staat, MD, MPH – Cincinnati Children's Hospital Medical Center; Eileen J. Klein, MD, MPH – Seattle Children's Hospital; Monica McNeal, MS – Cincinnati Children's Hospital Medical Center; Marian G. Michaels, MD, MPH – UPMC Children's Hospital of Pittsburgh; Leila C. Sahni, PhD, MPH – Texas Children’s Hospital; Laura S. Stewart, PhD – Vanderbilt University Medical Center; Peter G. Szilagyi, MD, MPH – University of California, Los Angeles; Christopher J. Harrison, MD – The Children's Mercy Hospital- Kansas City; Robert Hickey, MD – Childrens Hospital of Pittsburgh; Barbara Pahud, MD, MPH – The Children's Mercy Hospital; Jennifer E. Schuster, MD – Children's Mercy Hospital; Gina Weddle, DNP, RN, CPNP-AC/PC – Children's Mercy Hospital; Mary Moffatt, MD – The Children's Mercy Hospital; Joana Y. Lively, MPH – Centers for Disease Control and Prevention; Brian Rha, MD, MSPH – Centers for Disease Control and Prevention; Manish Patel, MD – Centers for Disease Control and Prevention
• Individual and State-level Factors Associated with Receipt of Multiple Recommended Adolescent Vaccines in the United States
  Elizabeth M. La, PhD – RTI Health Solutions; Diana Garbinsky, MS – RTI Health Solutions; Shannon Hunter, MS – RTI Health Solutions; Sara Poston, PharmD – GSK; Patricia Novy, PhD – GSK; Parinaz Ghaswalla, PhD, ORCID: 0000-0002-2883-5590 – GSK